Rohto Pharmaceutical Co Ltd

Common Name

Rohto Pharmaceutical

Country

Japan

Sector

Consumer Defensive

Industry

Household & Personal Products

Employees

9,144

Ticker

4527

Exchange

TOKYO STOCK EXCHANGE

Website

www.rohto.co.jp

Description

Rohto Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical industry, specializing in the research, development, and distribution of a diverse range of health and wellness products. Est... Show more

Financial Statements of Rohto Pharmaceutical

Below are the financial statements of Rohto Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of JPY	2024	2023
Net sales	270.84^a	238.66^a
Cost of sales	-113.55^a	-101.24^a
Gross profit	157.29^a	137.42^a
Selling, general and administrative expenses	—	—
Promotion expenses	-16.24^a	-14.42^a
Advertising expenses	-37.98^a	-32.05^a
Salaries and bonuses	-19.81^a	-18.28^a
Provision for bonuses	-1.53^a	-1.51^a
Provision for bonuses for directors (and other officers)	-0.05^a	-0.05^a
Retirement benefit expenses	-0.62^a	-0.63^a
Depreciation	-1.99^a	-1.96^a
Amortization of goodwill	-0.44^a	-0.38^a
Research and development expenses	-13.39^a	-11.07^a
Provision of allowance for doubtful accounts	-0.05^a	-0.2^a
Other	-25.15^a	-22.92^a
Total selling, general and administrative expenses	-117.24^a	-103.46^a
Operating profit	40.05^a	33.96^a
Non-operating income	—	—
Interest income	1.52^a	0.96^a
Dividend income	0.49^a	0.46^a
Share of profit of entities accounted for using equity method	0^a	0.06^a
Foreign exchange gains	0.45^a	0.35^a
Reversal of allowance for doubtful accounts	0.12^a	0^a
Gain on investments in investment partnerships	0^a	0.86^a
Other	0.97^a	1.01^a
Total non-operating income	3.55^a	3.7^a
Non-operating expenses	—	—
Interest expenses	-0.2^a	-0.25^a
Share of loss of entities accounted for using equity method	-0.29^a	0^a
Loss on investments in investment partnerships	-0.21^a	0^a
Provision of allowance for doubtful accounts	0^a	-0.42^a
Donations	0^a	-1^a
Other	-0.47^a	-0.42^a
Total non-operating expenses	-1.16^a	-2.09^a
Ordinary profit	42.43^a	35.57^a

Download Data

Verified Sources Behind Rohto Pharmaceutical’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Rohto Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Rohto Pharmaceutical's Financial Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Rohto Pharmaceutical Co Ltd

Financial Statements of Rohto Pharmaceutical

Verified Sources Behind Rohto Pharmaceutical’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Kobayashi Pharmaceutical Co Ltd

Lion Corp

Unicharm Corp

NH Foods Ltd

Japan Tobacco Inc

Seven & i Holdings Co Ltd